Zobrazeno 1 - 10
of 15 370
pro vyhledávání: ''
Autor:
Lajos Pusztai, Gabriel N. Hortobagyi, Bryan T. Hennessy, Massimo Cristofanilli, Chafika Mazouni, Fabrice Andre, Attila Tordai, W. Fraser Symmans, Cornelia Liedtke, Marjorie C. Green, Ana M. Gonzalez-Angulo, Kenneth R. Hess, Jaime A. Mejia
Publikováno v:
Journal of Clinical Oncology. 41:1809-1815
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. In this study, we compared response to neoadjuvant chemotherap
Publikováno v:
Journal of Clinical Oncology. 41:1331-1338
PURPOSE Immunohistochemistry (IHC) is a newer technique for assessing the estrogen receptor (ER) status of breast cancers, with the potential to overcome many of the shortcomings associated with the traditional ligand-binding assay (LBA). The purpose
Autor:
Charles Coutant, Catherine Loustalot, Marie-Martine Padeano, Laura Vincent, Aurélie Bertaut, Hélène Costaz, K. Peignaux, M. Rouffiac, Isabelle Desmoulins, Delphine Boulle, Clémentine Jankowski, Françoise Beltjens, Sylvain Causeret, Laurent Arnould, Sylvain Ladoire
Publikováno v:
Bulletin du Cancer. 109:268-279
Summary Purpose In the ACOSOG Z0011 trial, patients with primary breast cancer and 1–2 tumor-involved sentinel lymph nodes (SLNs) undergoing breast-conserving surgery had no oncological outcome benefit after axillary lymph node dissection (ALND), d
Autor:
Alan Nichol, Elisa K. Chan, Stephen Chia, Caroline Lohrisch, Nafisha Lalani, Lovedeep Gondara, Karen A. Gelmon, Daegan Sit, Eric Tran, Caroline Speers
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:861-869
Randomized clinical trials have shown that regional nodal irradiation (RNI) in patients with unselected N1 breast cancer improves breast cancer-specific survival. However, the benefit of RNI in women with biologically low-risk N1 breast cancer is unc
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
BMC cancer, 22(1):130
BMC Cancer
BMC cancer, 22(1):130
BMC Cancer
BackgroundWe aimed to explore the potential of German claims data for describing initial and long-term treatment patterns of breast cancer patients undergoing surgery.MethodsUsing the German Pharmacoepidemiological Research Database (GePaRD, ~ 20% of
Autor:
Debra L. Barton, Stephanie L. Pugh, Patricia A. Ganz, Steven C. Plaxe, Bridget F. Koontz, Jeanne Carter, Natalya Greyz-Yusupov, Seth J. Page, Kendrith M. Rowland, Ernie P. Balcueva, Sobia Nabeel, Jack B. Basil, Matthew L. Hill, Carolyn Y. Muller, Maria C. Bell, Snehal Deshmukh, Lisa A. Kachnic
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 40, iss 4
PURPOSE Because of the negative impact of cancer treatment on female sexual function, effective treatments are warranted. The purpose of this multisite study was to evaluate the ability of two dose levels of extended-release bupropion, a dopaminergic
Publikováno v:
Clinical Breast Cancer. 22:e232-e238
Objective To evaluate factors contributing to positive surgical margins associated with reflector guidance for patients undergoing breast conserving therapy for malignancy. Materials and Methods A retrospective IRB-approved review of our institutiona
Publikováno v:
Clinical Breast Cancer. 22:170-177
Background Accurate assessment of the axillary lymph nodes (aLNs) in breast cancer patients is essential for prognosis and treatment planning. Current radiological staging of nodal metastasis has poor accuracy. This study aimed to investigate the mac
Autor:
Courtney Andrews, Timothy C. Childers, Kimberly D. Wiseman, Valerie Lawhon, Stacey Ingram, Mary Lou Smith, Antonio C. Wolff, Lynne Wagner, Gabrielle B. Rocque
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
BMC Cancer
BMC Cancer
Background As the combination of systemic and targeted chemotherapies is associated with severe adverse side effects and long-term health complications, there is interest in reducing treatment intensity for patients with early-stage breast cancer (EB
A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer
Autor:
Mohammad Muhsin Chisti, Swechchha Silwal, Geetha Krishnamoorthy, Siddhartha Yadav, Sumeet Kumar Yadav
Publikováno v:
Clinical Breast Cancer. 22:161-169
Introduction Triple-negative breast cancer (TNBC) in men is very rare. The clinical characteristics, prognostic factors, and overall survival of men with TNBC have not been characterized. Methods The study population consisted of men and women with a